Free Trial

Regulus Therapeutics (RGLS) Insider Trading & Ownership

Regulus Therapeutics logo
$1.59 +0.04 (+2.58%)
(As of 12/20/2024 05:16 PM ET)

Regulus Therapeutics (NASDAQ:RGLS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.35%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7,280.00
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$23,857.12
Get RGLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Regulus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RGLS Insider Buying and Selling by Quarter

Regulus Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/25/2024Kathryn J CollierDirectorBuy4,000$1.82$7,280.00  
1/18/2024Crispina CalsadaCFOSell5,468$1.19$6,506.92  
1/18/2024Joseph P HaganCEOSell14,580$1.19$17,350.20  
(Data available from 1/1/2013 forward)

RGLS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Regulus Therapeutics includes Crispina Calsada, Denis Drygin, Joseph P Hagan, and Kathryn J Collier. Learn more on insiders at RGLS.

4.35% of Regulus Therapeutics stock is owned by insiders. Learn more on RGLS's insider holdings.

The following insider purchased RGLS shares in the last 24 months: Kathryn J Collier ($7,280.00).

Insiders have purchased a total of 4,000 RGLS shares in the last 24 months for a total of $7,280.00 bought.

The following insiders have sold RGLS shares in the last 24 months: Crispina Calsada ($6,506.92), and Joseph P Hagan ($17,350.20).

Insiders have sold a total of 20,048 Regulus Therapeutics shares in the last 24 months for a total of $23,857.12 sold.

Regulus Therapeutics Key Executives



This page (NASDAQ:RGLS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners